VTEPA

• Etoposide
• Cisplatin
• Paclitaxel
• Vinorelbine

Name

Etoposide

Alternate Names

Dom-Etoposide

Epipodophyllotoxin derivative

Epipodophyllotoxin ethylidene gluco-pyranoside

Eposine

Ethylidene-Lignan P

Etopophos

Podophyllotoxin derivative

Vepesid

VP 16-213

VP-16

VP-16213

Toposar

Abbreviations

EPEG

VP-16

VP-16-213

Category

Chemotherapy

Subcategory

Epipodophyllotoxin, topoisomerase II inhibitor

Plant alkaloid

NSC Number

141540

Primary Site

Gastric cancer

Hodgkins lymphoma

Lung cancer (NSCLC, SCLC)

Non-Hodgkin lymphoma

testicular cancer (Germ cell tumors)

Histology

None

Remarks

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

Coding

This drug should be coded

Name

Cisplatin

Alternate Names

Cis-Platin

Cis-Platinum II#

Cisplatino (Spanish)

Cisplatinum

Cisplatyl

Neoplatin

Peyrone's chloride

Platinex

Platinol

Platinol-AQ

Platinol-AQ VHA Plus

Platinum

Abbreviations

CACP

CDDP

Cis-DDP

CPD

CPDC

CPDD

CPPD

DDP

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

119875

Primary Site

Bladder

ovarian

testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Paclitaxel

Alternate Names

BMS-181339-01

BMY-45622

Taxol

Abbreviations

None

Category

Chemotherapy

Subcategory

Mitotic inhibitor

plant alkaloid

Taxane

NSC Number

125973

673089

Primary Site

breast

Gastric

head & neck cancer

Kaposi's sarcoma

non-small cell lung cancers

ovarian

Histology

None

Remarks

Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.

Coding

This drug should be coded

Name

Vinorelbine

Alternate Names

Navelbine

Navelbine ditartrate

Vinorelbine Ditartrate

Vinorelbine Tartrate

Abbreviations

VNB

Category

Chemotherapy

Subcategory

Plant alkyloid

NSC Number

608210

Primary Site

Breast

lung cancer

Histology

None

Remarks

Phase III NSCLC Vinca alkaloid; mitotic inhibitor. FDA approved use on NSCLC. GlaxoSmithKline.

Coding

This drug should be coded